Cbd Life Sciences Inc.

09/19/2024 | Press release | Distributed by Public on 09/19/2024 04:02

Securities Offering by Private Issuer - Form 253G2

Filed Pursuant to Rule 253(g)(2)

File No. 024-12430

Offering Circular Supplement

Dated September 19, 2024

A Post-Qualification Amendment No. 2 to an Offering Statement (the "Amendment") pursuant to Regulation A relating to these securities has been filed with the Securities and Exchange Commission ("SEC"). The Amendment was Qualified on September 17, 2024.

This Post-Qualification Offering Circular Amendment No. 2 Supplement covers a change in the offering price of the shares offered from $0.00045 to $0.00036 per share. This change affects only the dilution and gross proceeds.

We may elect to satisfy our obligation to deliver a Final Offering Circular by sending you a notice within two business days after the completion of our sale to you that contains the URL where the Final Offering Circular or the Offering Statement in which such Final Offering Circular was filed may be obtained.